Merck to pay $5bn in rofecoxib claims.
Charatan
Fred
F
D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects / Q000191:economics*; D004345:Drug Industry / Q000191:economics* / Q000331:legislation & jurisprudence; D007603:Jurisprudence; D007783:Lactones / Q000009:adverse effects / Q000191:economics*; D013450:Sulfones / Q000009:adverse effects / Q000191:economics*; D014481:United States
D052246:Cyclooxygenase 2 Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib